NCT05707208View on ClinicalTrials.gov

A Randomized, Controlled Study of Repeat Dose Sustained Release Lidocaine for Treatment of Chronic Scrotal Pain

PHASE2RecruitingINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

October 31, 2025

Conditions
Chronic Pain
Interventions
DRUG

ST-01

A sustained release lidocaine formulation designed for the treatment of acute and chronic pain.

DRUG

1% Lidocaine HCL

Currently approved lidocaine

Trial Locations (8)

T2V 1P9

RECRUITING

Prostate Cancer Centre - Rockyview Hospital, Calgary

V1Y 1T2

RECRUITING

Kelowna General Hospital Clinical Research Department, Kelowna

V5Z 1M9

RECRUITING

Vancouver Prostate Centre, Vancouver

R3P 2S8

RECRUITING

Men's Health Clinic Manitoba, Winnipeg

L6T 4S5

RECRUITING

Jonathan Giddens Medicine Professional Corporation, Brampton

L6H 3P1

RECRUITING

The Fe/Male Health Centre, Oakville

M5T 3L9

RECRUITING

Mount Sinai Hospital - Men's Health Institute, Toronto

H3M 1L3

RECRUITING

THEO Medical, Montreal

All Listed Sponsors
lead

Sustained Therapeutics Inc.

INDUSTRY